EP4081664A4 - Microbiome optimization - Google Patents

Microbiome optimization Download PDF

Info

Publication number
EP4081664A4
EP4081664A4 EP20905639.9A EP20905639A EP4081664A4 EP 4081664 A4 EP4081664 A4 EP 4081664A4 EP 20905639 A EP20905639 A EP 20905639A EP 4081664 A4 EP4081664 A4 EP 4081664A4
Authority
EP
European Patent Office
Prior art keywords
microbiome
optimization
microbiome optimization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20905639.9A
Other languages
German (de)
French (fr)
Other versions
EP4081664A1 (en
Inventor
Joanna E. Ellington
G.D. Clifton
Rayne ELLINGTON-LAWRENCE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glyciome LLC
Original Assignee
Glyciome LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/943,895 external-priority patent/US20200360675A1/en
Application filed by Glyciome LLC filed Critical Glyciome LLC
Publication of EP4081664A1 publication Critical patent/EP4081664A1/en
Publication of EP4081664A4 publication Critical patent/EP4081664A4/en
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Primary Health Care (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Databases & Information Systems (AREA)
  • Business, Economics & Management (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Data Mining & Analysis (AREA)
  • General Business, Economics & Management (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Electroluminescent Light Sources (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP20905639.9A 2019-12-23 2020-12-19 Microbiome optimization Pending EP4081664A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962953068P 2019-12-23 2019-12-23
US202063005243P 2020-04-04 2020-04-04
US16/943,895 US20200360675A1 (en) 2019-12-23 2020-07-30 Kits for topical,isotonic compositions
US202063075132P 2020-09-05 2020-09-05
PCT/US2020/066269 WO2021133697A1 (en) 2019-12-23 2020-12-19 Microbiome optimization

Publications (2)

Publication Number Publication Date
EP4081664A1 EP4081664A1 (en) 2022-11-02
EP4081664A4 true EP4081664A4 (en) 2024-01-10

Family

ID=76574670

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20905639.9A Pending EP4081664A4 (en) 2019-12-23 2020-12-19 Microbiome optimization

Country Status (3)

Country Link
EP (1) EP4081664A4 (en)
AU (1) AU2020415366A1 (en)
WO (1) WO2021133697A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018013583A2 (en) * 2016-07-11 2018-01-18 The Brigham And Women's Hospital, Inc. Medicinal vaginal lactobacillus cocktail
WO2020123559A1 (en) * 2018-12-11 2020-06-18 Glyciome, Llc Topical, isotonic compositions for genital use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6537538B2 (en) * 2000-12-18 2003-03-25 Rush-Presbyterian-St. Luke's Medical Center Method for the prevention, inhibition, or treatment of vaginitis and/or bacterial vaginosis using polystyrene sulfonate
CA2609754C (en) * 2005-04-27 2012-01-10 Shenzhen Phlora Biotechnology Limited Compositions of benzoic acid and saccharides for regulating and maintaining bacterial flora and acidity in the vagina
WO2018044967A1 (en) * 2016-08-31 2018-03-08 Virginia Commonwealth University Local delivery of cholesterol-lowering drugs to treat and prevent bacterial vaginosis
JP6780123B2 (en) * 2016-10-09 2020-11-04 深▲せん▼優麗康生物技術有限公司Ｓｈｅｎｚｈｅｎ Ｅｕｌｉｋａｎ Ｂｉｏｔｅｃｈｎｏｌｏｇｙ Ｃｏ．， Ｌｔｄ． Applications for the preparation of vaginal compositions containing bacteriostatic agents and vaginal compositions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018013583A2 (en) * 2016-07-11 2018-01-18 The Brigham And Women's Hospital, Inc. Medicinal vaginal lactobacillus cocktail
WO2020123559A1 (en) * 2018-12-11 2020-06-18 Glyciome, Llc Topical, isotonic compositions for genital use

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
IMBERT MARLÈNE ET AL: "On the Iron Requirement of Lactobacilli Grown in Chemically Defined Medium", CURRENT MICROBIOLOGY, vol. 37, no. 1, 1 July 1998 (1998-07-01), New York, pages 64 - 66, XP093106353, ISSN: 0343-8651, DOI: 10.1007/s002849900339 *
ROUSSEAU V ET AL: "Prebiotic effects of oligosaccharides on selected vaginal lactobacilli and pathogenic microorganisms", ANAEROBE, ELSEVIER, AMSTERDAM, NL, vol. 11, no. 3, 1 June 2005 (2005-06-01), pages 145 - 153, XP004807462, ISSN: 1075-9964, DOI: 10.1016/J.ANAEROBE.2004.12.002 *
See also references of WO2021133697A1 *
YANG LIN ET AL: "Bornyl acetate suppresses ox-LDL-induced attachment of THP-1 monocytes to endothelial cells", BIOMEDICINE & PHARMACOTHERAPY, vol. 103, 1 July 2018 (2018-07-01), FR, pages 234 - 239, XP093106343, ISSN: 0753-3322, DOI: 10.1016/j.biopha.2018.03.152 *

Also Published As

Publication number Publication date
EP4081664A1 (en) 2022-11-02
AU2020415366A1 (en) 2022-07-14
WO2021133697A1 (en) 2021-07-01

Similar Documents

Publication Publication Date Title
EP3867745A4 (en) Hyperpiler
EP3781482A4 (en) Nano-satellite
EP3833739A4 (en) Akkermansia muciniphila
EP3712112A4 (en) Gis-type zeolite
EP3976107A4 (en) Sonosensitization
EP3993798A4 (en) Novel methods
EP4069240A4 (en) Combinations
EP4069235A4 (en) Combinations
EP4069225A4 (en) Combinations
EP4034119A4 (en) Novel methods
EP4006211A4 (en) Slide member
EP4069234A4 (en) Combinations
EP4069242A4 (en) Combinations
EP4003420A4 (en) Il-38-specific antiobodies
EP4073971A4 (en) Quasi-colocation configuration
EP4040154A4 (en) Immunochromatography
EP3778005A4 (en) Adsorbent
EP4081664A4 (en) Microbiome optimization
EP4072433A4 (en) Septalcrossingsystem
EP3990820A4 (en) Cryosphere
EP4069224A4 (en) Combinations
EP4069236A4 (en) Combinations
EP4069241A4 (en) Combinations
AU2019904806A0 (en) Fastcast-3
AU2019904733A0 (en) Trolleyon

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220721

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: C12Q0001688300

Ipc: A61K0031045000

A4 Supplementary search report drawn up and despatched

Effective date: 20231211

RIC1 Information provided on ipc code assigned before grant

Ipc: G16H 50/20 20180101ALI20231205BHEP

Ipc: G16H 50/30 20180101ALI20231205BHEP

Ipc: G16H 40/67 20180101ALI20231205BHEP

Ipc: G16H 40/63 20180101ALI20231205BHEP

Ipc: G16H 20/13 20180101ALI20231205BHEP

Ipc: G16H 10/40 20180101ALI20231205BHEP

Ipc: A61P 15/00 20060101ALI20231205BHEP

Ipc: G16H 20/10 20180101ALI20231205BHEP

Ipc: C12Q 1/689 20180101ALI20231205BHEP

Ipc: C12Q 1/6883 20180101ALI20231205BHEP

Ipc: A61K 47/14 20170101ALI20231205BHEP

Ipc: A61K 33/32 20060101ALI20231205BHEP

Ipc: A61K 31/7016 20060101ALI20231205BHEP

Ipc: A61K 31/045 20060101AFI20231205BHEP